 1.  Short title This Act may be cited as the  Protecting Access to Safe and Effective Medicines Act of 2021 .
 2.  Clarifying the meaning of new chemical entity  Chapter V of the Federal Food, Drug, and Cosmetic Act is amended—  (1) in section 505 ( 21 U.S.C. 355 )— (A)  in subsection (c)(3)(E)—  (i) in clause (ii), by striking  active ingredient (including any ester or salt of the active ingredient)  and inserting  active moiety (as defined by the Secretary in section 314.3 of title 21, Code of Federal Regulations (or any successor regulations)) ; and (ii) in clause (iii), by striking  active ingredient (including any ester or salt of the active ingredient)  and inserting  active moiety (as defined by the Secretary in section 314.3 of title 21, Code of Federal Regulations (or any successor regulations)) ; (B)  in subsection (j)(5)(F)—  (i) in clause (ii), by striking  active ingredient (including any ester or salt of the active ingredient)  and inserting  active moiety (as defined by the Secretary in section 314.3 of title 21, Code of Federal Regulations (or any successor regulations)) ; and (ii) in clause (iii), by striking  active ingredient (including any ester or salt of the active ingredient)  and inserting  active moiety (as defined by the Secretary in section 314.3 of title 21, Code of Federal Regulations (or any successor regulations)) ; (C) in subsection (l)(2)(A)(i), by striking  active ingredient (including any ester or salt of the active ingredient)  and inserting  active moiety (as defined by the Secretary in section 314.3 of title 21, Code of Federal Regulations (or any successor regulations)) ; (D) in subsection (s), in the matter preceding paragraph (1), by striking  active ingredient (including any ester or salt of the active ingredient)  and inserting  active moiety (as defined by the Secretary in section 314.3 of title 21, Code of Federal Regulations (or any successor regulations)) ; and (E)  in subsection (u)(1), in the matter preceding subparagraph (A)—  (i) by striking  active ingredient (including any ester or salt of the active ingredient)  and inserting  active moiety (as defined by the Secretary in section 314.3 of title 21, Code of Federal Regulations (or any successor regulations)) ; and (ii) by striking  same active ingredient  and inserting  same active moiety ; (2) in section 512(c)(2)(F) ( 21 U.S.C. 360b(c)(2)(F) )— (A) in clause (i), by striking  active ingredient (including any ester or salt of the active ingredient)  and inserting  active moiety (as defined by the Secretary in section 314.3 of title 21, Code of Federal Regulations (or any successor regulations)) ; (B) in clause (ii), by striking  active ingredient (including any ester or salt of the active ingredient)  and inserting  active moiety (as defined by the Secretary in section 314.3 of title 21, Code of Federal Regulations (or any successor regulations)) ; and (C) in clause (v), by striking  active ingredient (including any ester or salt of the active ingredient)  and inserting  active moiety (as defined by the Secretary in section 314.3 of title 21, Code of Federal Regulations (or any successor regulations)) ; (3) in section 524(a)(4)(C) ( 21 U.S.C. 360n(a)(4)(C) ), by striking  active ingredient (including any ester or salt of the active ingredient)  and inserting  active moiety (as defined by the Secretary in section 314.3 of title 21, Code of Federal Regulations (or any successor regulations)) ; (4) in section 529(a)(4)(A)(ii) ( 21 U.S.C. 360ff(a)(4)(A)(ii) ), by striking  active ingredient (including any ester or salt of the active ingredient)  and inserting  active moiety (as defined by the Secretary in section 314.3 of title 21, Code of Federal Regulations (or any successor regulations)) ; and (5) in section 565A(a)(4)(D) (21 U.S.C. 360bbb–4a(a)(4)(D)), by striking  active ingredient (including any ester or salt of the active ingredient)  and inserting  active moiety (as defined by the Secretary in section 314.3 of title 21, Code of Federal Regulations (or any successor regulations)) .
